Cannabis and hemp decontamination technology company Willow Industries has closed a $2-million venture funding round.
The round, co-lead by AFI Capital Partners and WelCan Capital, included Halley Venture Partners and Flatiron Venture Partners.
Need more cannabis news? Check out all of our coverage here.
“Microbial contaminants pose a major health risk to consumers who utilize medical cannabis for numerous conditions, and whose upper airway and immune systems are compromised,” said Dr. Ramie Tritt, an ENT and nasal-sinus surgeon.
“Willow has developed a solution to reduce or eliminate microbial contaminants without compromising the medicinal and recreational properties of the flower to allow safe use of cannabis.”
The closing of Willow's first institutional funding round is "monumental" for the company, CEO Jill Ellsworth told Benzinga.
"We now have the power and strength behind us to execute our lofty visions and continue accelerating everything we have already accomplished. The funding also strengthens our position as a leader in cannabis safety.”
Related Links:
Cannabis Stock Gainers And Losers From June 11
Photo courtesy of Willow Industries.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.